CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 157,689 enrolled
Drug / intervention
WHO Safe Childbirth Checklist Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02148952
NCT02148952N/ACompleted

A Matched-pair, Cluster Randomized Trial to Measure the Efficacy of the WHO Safe Childbirth Checklist Program on Severe Maternal, Fetal and Newborn Harm

Harvard School of Public Health (HSPH)·interventional·Posted May 29, 2014·Updated Jun 26, 2024

In Brief

A clinical study evaluating WHO Safe Childbirth Checklist Program for Maternal Death and 3 related conditions. Completed, enrolled 157,689 participants across 1 site.

Detailed Summary

The purpose of this study is to measure the impact of a checklist-based childbirth safety program (the WHO Safe Childbirth Checklist Program) on reduction of severe maternal, fetal, and newborn harm in institutional deliveries in north India.

Study Details

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 29, 2014
Enrollment StartNov 1, 2014
Primary CompletionJan 20, 2017
Study CompletionJul 18, 2017
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 12.1 years ago

Interventions

WHO Safe Childbirth Checklist Programbehavioral

The IHF group will receive the WHO Safe Childbirth Checklist Program designed to maximize likelihood of effective and sustained uptake of the program by birth attendants in the designated facilities. The program includes three key implementation steps that involve: engagement of leadership and clinicians at the state, district, and local levels, a formal launch to introduce the Checklist, and support through peer coaching and data feedback. The intervention facilities will also receive a standardized maternity register to ensure appropriate data collection.